Trials / Completed
CompletedNCT01715246
Clinical Safety of a New Infant Starter Formula Containing 2 Human Milk Oligosaccharides (HMOs)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 176 (estimated)
- Sponsor
- Société des Produits Nestlé (SPN) · Industry
- Sex
- All
- Age
- 14 Days
- Healthy volunteers
- Accepted
Summary
The primary objective of this clinical study is to show that infants fed a standard starter infant formula with 2 Human Milk Oligosaccharides (HMOs) have a growth in line with infants fed a standard starter infant formula without HMOs.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Infant Formula |
Timeline
- Start date
- 2012-10-01
- Primary completion
- 2014-12-01
- Completion
- 2015-07-01
- First posted
- 2012-10-26
- Last updated
- 2015-09-11
Locations
2 sites across 2 countries: Belgium, Italy
Source: ClinicalTrials.gov record NCT01715246. Inclusion in this directory is not an endorsement.